Available on demand: What's next for patient-centricity?

This webinar delved into the challenges that pharma face when looking at their patient-centricity strategy, and the opportunities that exist with this approach. We explored the key motivators for this approach, and steps to overcome the internal and external barriers, and most importantly – how do pharma companies know when they have become truly patient-centric? How should they measure the impact of their strategy through the lifecycle of a drug and their business as a whole?

Participant line up:

Dr Paul Robinson, Executive Director, Patient Perspectives at MSD

Paul has been with MSD for 22 years, in Medical Affairs and Clinical Research Operations, in both the UK and the US. In 2015 he moved into a newly created role, to engage with patients and improve dialogue with the Scientific, Medical & Patient communities, ensuring that their perspective and voice is heard within the company, and influences decisions with the aim of improving decision making in all aspects of drug development in the interest of patients, from basic research all the way through to patent expiry.  Paul remains a practising physician and also sits on a Technology Appraisal Committee at NICE in the UK.

Andrew Schorr, Co-Founder & President, Patient Power LLC

Andrew is a medical journalist and patient advocate living with two blood cancers: chronic lymphocytic leukemia and myelofibrosis. For CLL, participation in a phase II clinical trial led to a remission that has continued to 16 years. For myelofibrosis, an oncogene inhibitor oral medicine has provided significant control. In partnership with his wife, Esther, Andrew has been a pioneer in online and video patient education for chronic illnesses and cancer since 1984 and, since 2005, as co-founder of Patient Power, a leading digital channel for thousands of cancer patients in the U.S. and Europe. He is author of the acclaimed book The Web-Savvy Patient. Patient Power, through it’s patientpower.info, patientpower.eu and partner websites like oncologytube.com and social media reaches an estimated 100,000 cancer patients per month. In-person educational events at major medical centers on specific cancers and from medical conferences in the US and Europe are broadcast live and content reaches several thousand patients per event.

Jo Fearnhead-Wymbs, Patient Engagement Director, Ashfield Healthcare Communications

Jo Fearnhead-Wymbs is Patient Engagement Director at Ashfield Healthcare Communications, with over 10 years’ experience in the industry. Having joined Ashfield Healthcare Communications in 2012, Jo has 6 years’ experience working in a patient-focused role, developing patient support initiatives and working with pharma clients to identify where they could engage with patients to improve outcomes. Jo was responsible for driving the virtual patient forum and is extremely passionate about making a difference to patients, in a way that makes sense to pharma.

Anita Osborn, Clinical Services Director, Ashfield Clinical

Anita is Clinical Services Director at Ashfield Clinical and as such is a strategic consultant to pharmaceutical companies in the creation of sponsored patient support programmes across the UK and Europe, as well as an active supervisor of these programmes.

The live webinar took place on Tuesday 5 July at 15.00 BST / 10.00 EDT. To view this debate on demand, click here or on the button above/below.